AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Changfan Lin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. Hauptthemen laut MEDLINE: Dependovirus, Brain, Carbonic Anhydrase IV, Gene Transfer Techniques. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIMH NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Gene therapies using natural adeno-associated virus (AAV) serotypes have restricted applications, particularly in the brain, due to their poor targeting and resulting safety concerns. Directed evolution has identified brain-enhanced engineered AAV capsids for various model organisms, but inter-species differences challenge their translation. Here, we engineer AAVs to target human carbonic anhydrase IV (CA-IV), a recently identified blood-brain barrier transcytosis receptor with several favorable properties. We perform in vitro on-column selection of an AAV library to exclude capsids that do not target human CA-IV. We subsequently screen the top 0.01% of variants in vivo in mice expressing human CA-IV in brain endothelial cells. Notably, two top-performing capsids in "humanized" mice are relatively lower ranked in vitro and outperform several top-ranked in vitro candidates. One of these, AAV-hCA4-IV77, achieves 100-fold-greater brain transduction than AAV9, with robust neuronal and astrocytic coverage across brain regions. These results advance our understanding of receptor-targeted capsid design and support the therapeutic potential of human CA-IV-engaging AAVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
- Department of Biological Sciences, California State Polytechnic University Pomona, Pomona, CA, USA.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. Electronic address: viviana@caltech.edu.
Förderung
- NINDS NIH HHS
- NIMH NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute of Mental Health
- California Institute of Technology Beckman Institute
- Friedreich's Ataxia Research Alliance
- National Cancer Institute
- National Institute on Drug Abuse
Zitieren
APA
Lin, C., Chen, X., Hoang, J. D., Ristic, F., Fan, Y., Jang, S., Chung, J. H. A., Sullivan, E. E., Gawda, T., Kavvathas, B., Tran, I., Li, Y., Steele, A. D., Shay, T. F., & Gradinaru, V. (2025). AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116419
Vancouver
Lin C, Chen X, Hoang JD, Ristic F, Fan Y, Jang S, et al. AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116419
BibTeX
@article{Lin2025,
author = {Lin, Changfan and Chen, Xinhong and Hoang, Jonathan D and Ristic, Fiona and Fan, Yujie and Jang, Seongmin and Chung, Jin Hyung Alex and Sullivan, Erin E and Gawda, Tomasz and Kavvathas, Bill and Tran, Irene and Li, Yitong and Steele, Andrew D and Shay, Timothy F and Gradinaru, Viviana},
title = {AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116419}
}
EUVIMED